Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/03/25/2851589/33240/en/Emergent-BioSolutions-Receives-NAI-Status-for-Baltimore-Bayview-Manufacturing-Facility.html
https://www.globenewswire.com//news-release/2024/03/06/2841810/33240/en/Emergent-BioSolutions-Reports-Fourth-Quarter-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2024/02/29/2837808/33240/en/Emergent-BioSolutions-to-Release-Fourth-Quarter-Full-Year-2023-Financial-Results-and-Conduct-Conference-Call-on-March-6-2024.html
https://www.fiercepharma.com/manufacturing/emergent-snares-2358m-us-contract-provide-anthrax-vaccine
https://endpts.com/emergent-nabs-us-government-contract-of-up-to-235-8m-for-anthrax-vaccine/
https://www.globenewswire.com//news-release/2024/01/11/2807893/33240/en/Emergent-BioSolutions-Awarded-Procurement-Contract-Valued-up-to-235-8-Million-to-Supply-BioThrax-Anthrax-Vaccine-Adsorbed-to-the-U-S-Department-of-Defense.html
https://www.globenewswire.com//news-release/2024/01/09/2806181/33240/en/Emergent-BioSolutions-to-Present-at-the-42nd-Annual-J-P-Morgan-Healthcare-Conference-on-January-11-2024.html
https://www.fiercepharma.com/pharma/after-cyfendus-full-approval-emergent-clinches-75m-anthrax-vaccine-supply-pact-us
https://www.globenewswire.com//news-release/2023/11/24/2785559/33240/en/Emergent-BioSolutions-Receives-NYSE-Notice-Regarding-Delayed-Form-10-Q-Filing.html
https://www.globenewswire.com//news-release/2023/11/08/2776840/33240/en/Emergent-BioSolutions-Reports-Third-Quarter-2023-Financial-Results.html